Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract infections in children under two years old, resulting in significant morbidity and a heavy economic burden on healthcare ...

Respiratory illnesses like influenza, COVID-19 and respiratory syncytial virus (RSV) are leading to many people being ...

Revenue for Arexvy and Abrysvo fell sharply year over year in the fourth quarter due to narrower U.S. guidelines for their ...

Of all the things you can get sick with this winter, respiratory syncytial virus (RSV) should be top of mind. With positivity rates in Canada reaching record highs, it’s especially important for older ...

Research reveals that even low levels of air pollution significantly increase the risk of respiratory infections in adults, ...

Despite the slightly warmer weather and longer periods of sunshine, we are still in the depths of cold and flu season, a ...

Many nursing home residents are refusing COVID shots this winter, though flu vaccine penetration has remained strong historically.

Seven-year-old Harmony from Sheffield is supporting The Children’s Hospital Charity by taking part in Theo’s Pyjama Day in ...

More than 86,000 recorded cases of respiratory syncytial virus in 2024 were in children younger than four years old.

North Carolina reports a spike in flu cases and 117 deaths, urging the public to get vaccinated and seek early treatment.

Nirsevimab is protective against RSV infections and coinfections, which suggests there is no replacement of RSV with other viruses post-nirsevimab administration.